IRMD.NASDAQIradimed CORP

Form 4: Iradimed Corp Executive Receives Stock Grants Under Incentive Plans

Sentiment:

Stock Grant Filing


Anthony Vuoto, an executive at Iradimed Corp, received restricted stock units under the company's 2014 and 2023 Equity Incentive Plans, which will vest in installments and convert to common stock.

Summary

  • Anthony Vuoto received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan on December 7, 2022.
  • These restricted stock units vest in two equal annual installments starting on December 7, 2023.
  • Upon vesting, the reporting person will receive common stock equal to the number of vested restricted stock units.
  • On December 7, 2023, the reporting person received additional restricted stock units under Iradimed Corporation's 2023 Equity Incentive Plan.
  • These restricted stock units vest in two equal annual installments beginning on December 7, 2024.
  • The restricted stock units convert into common stock on a one-for-one basis.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate practice of granting stock-based compensation, which is generally viewed positively for aligning executive and shareholder interests. There are no negative implications.

Positives

  • The granting of restricted stock units aligns executive interests with shareholder value.
  • The vesting schedule encourages long-term performance and retention of the executive.

Risks

  • The potential dilution of existing shares upon conversion of the restricted stock units.

Future Outlook

The document outlines the vesting schedule for the restricted stock units, indicating future stock issuance upon vesting.

Industry Context

Stock-based compensation is a common practice in the corporate world to incentivize and retain key executives.

Comparison to Industry Standards

  • Many companies in the medical device industry use restricted stock units as part of their executive compensation packages.
  • The vesting schedule of two equal annual installments is a fairly standard approach for these types of grants.
  • Companies like Stryker, Medtronic, and Boston Scientific also utilize similar equity-based compensation plans.

Stakeholder Impact

  • Shareholders may experience minor dilution upon the conversion of restricted stock units to common stock.
  • The stock grants are intended to incentivize the executive, which could benefit the company's performance and thus shareholders.

Next Steps

  • The restricted stock units will vest according to the specified schedule.
  • Upon vesting, the executive will receive shares of common stock.

Key Dates

DateDescription
2022-12-07Anthony Vuoto received restricted stock units under the 2014 Equity Incentive Plan.
2023-12-07First vesting date for the 2014 Equity Incentive Plan restricted stock units and Anthony Vuoto received restricted stock units under the 2023 Equity Incentive Plan.
2024-12-07First vesting date for the 2023 Equity Incentive Plan restricted stock units.
2024-12-10Date of signature of the filing by Anthony Vuoto.

Keywords

restricted stock units, equity incentive plan, stock grants, vesting, common stock, Iradimed Corp, executive compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.